Literature DB >> 26300670

BRCA1/2 population screening: embracing the benefits.

S E Plon1.   

Abstract

Entities:  

Year:  2015        PMID： 26300670      PMCID： PMC4530817          DOI： 10.3747/co.22.2660

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  14 in total

1.  Cancer. A risky business--assessing breast cancer risk.

Authors:  Ephrat Levy-Lahad; Sharon E Plon
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

Review 2.  Population screening in the age of genomic medicine.

Authors:  Muin J Khoury; Linda L McCabe; Edward R B McCabe
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

3.  Screening for 185delAG in the Ashkenazim.

Authors:  C S Richards; P A Ward; B B Roa; L C Friedman; A A Boyd; G Kuenzli; J K Dunn; S E Plon
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-02-18       Impact factor: 25.391

5.  Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

Authors:  Mary-Claire King; Joan H Marks; Jessica B Mandell
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

6.  Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.

Authors:  Efrat Gabai-Kapara; Amnon Lahad; Bella Kaufman; Eitan Friedman; Shlomo Segev; Paul Renbaum; Rachel Beeri; Moran Gal; Julia Grinshpun-Cohen; Karen Djemal; Jessica B Mandell; Ming K Lee; Uziel Beller; Raphael Catane; Mary-Claire King; Ephrat Levy-Lahad
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-05       Impact factor: 11.205

7.  Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

Authors:  Noah D Kauff; Susan M Domchek; Tara M Friebel; Mark E Robson; Johanna Lee; Judy E Garber; Claudine Isaacs; D Gareth Evans; Henry Lynch; Rosalind A Eeles; Susan L Neuhausen; Mary B Daly; Ellen Matloff; Joanne L Blum; Paul Sabbatini; Richard R Barakat; Clifford Hudis; Larry Norton; Kenneth Offit; Timothy R Rebbeck
Journal:  J Clin Oncol       Date:  2008-02-11       Impact factor: 44.544

8.  Mammography behavior after receiving a negative BRCA1 mutation test result in the Ashkenazim: a community-based study.

Authors:  S E Plon; L E Peterson; L C Friedman; C S Richards
Journal:  Genet Med       Date:  2000 Nov-Dec       Impact factor: 8.822

9.  Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population.

Authors:  Kristin G Monaghan; Gerald L Feldman; Glenn E Palomaki; Elaine B Spector
Journal:  Genet Med       Date:  2008-01       Impact factor: 8.822

10.  Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.

Authors:  Ranjit Manchanda; Rosa Legood; Matthew Burnell; Alistair McGuire; Maria Raikou; Kelly Loggenberg; Jane Wardle; Saskia Sanderson; Sue Gessler; Lucy Side; Nyala Balogun; Rakshit Desai; Ajith Kumar; Huw Dorkins; Yvonne Wallis; Cyril Chapman; Rohan Taylor; Chris Jacobs; Ian Tomlinson; Uziel Beller; Usha Menon; Ian Jacobs
Journal:  J Natl Cancer Inst       Date:  2014-11-30       Impact factor: 13.506
View more
  2 in total

Review 1.  Population genetic testing for cancer susceptibility: founder mutations to genomes.

Authors:  William D Foulkes; Bartha Maria Knoppers; Clare Turnbull
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

2.  Age and perceived risks and benefits of preventive genomic screening.

Authors:  Margaret Waltz; R Jean Cadigan; Anya E R Prince; Debra Skinner; Gail E Henderson
Journal:  Genet Med       Date:  2017-12-07       Impact factor: 8.822
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.